Gene therapy strategies to improve the effectiveness of cancer radiotherapy (Q35925611)

11 August 2017

1 reference

title

Gene therapy strategies to improve the effectiveness of cancer radiotherapy (English)

1 reference

11 August 2017

0 references

Svend O Freytag

1

1 reference

11 August 2017

Jae Ho Kim

2

1 reference

11 August 2017

Stephen L Brown

3

1 reference

11 August 2017

Kenneth Barton

4

1 reference

11 August 2017

Mei Lu

5

1 reference

11 August 2017

Myung Chung

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Biological Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

1757-1770

1 reference

External beam radiotherapy dose response of prostate cancer

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Radiosensitizing nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Selective in vivo radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells transduced with the E. coli cytosine deaminase (CD) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenoviral-mediated p53 gene transfer to non-small cell lung cancer through endobronchial injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Phase I trial of recombinant human tumour necrosis factor α in patients with advanced malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Spatial and temporal control of gene therapy using ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenoviral TNF-α gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Inhibition of Nuclear Factor-κB Activity Is Involved in E1A-mediated Sensitization of Radiation-induced Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Anti‐erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

RAF antisense oligonucleotide as a tumor radiosensitizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Adenovirus-mediated gene transduction of truncated I kappa B alpha enhances radiosensitivity in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

ATM and ATR: networking cellular responses to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Hypersensitivity ofKu80-deficient cell lines and mice to DNA damage: The effects of ionizing radiation on growth, survival, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.4.11.1757

10.1517/14712598.4.11.1757

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference